Health

Fapon Donation Reaches 3 Million PCR Test Components Globally and Welcomes More Participation

DONGGUAN, China, March 30, 2020 /PRNewswire/ -- Fapon Biotech Inc . (Fapon), a global leading IVD raw materials and one-stop solutions company offering products and technologies to enable the rapid development and pro...

2020-03-30 20:15 1969

Lightinthebox Adding Packs of Medical Face Masks to Parcels Shipped to North America and Europe Free-of-Charge to Fight COVID-19 Pandemic

BEIJING, March 30, 2020 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a cross-border e-commerce platform that delivers products directly to consumers around the world, today announced that it is adding packs of medical face masks to parcels shipp...

2020-03-30 20:01 3999

RavenPack Launches Free Coronavirus News Monitor to Help Data-driven Professionals Face the Challenging New Market Conditions

NEW YORK, March 30, 2020 /PRNewswire/ -- In response to the coronavirus pandemic, RavenPack, a leading provider of big data analytics, has launched a live and interactive website to help navigate the oceans of information currently available on the novel coronavirus and its impact on world affair...

2020-03-30 20:00 1743

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest bySeptember 2020 Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capab...

2020-03-30 19:32 4095

Alphamab Oncology, Simcere and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China

SUZHOU, China, March 30, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966HK) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has established strategic partnership with Simcere and 3D Medicines (Beijing) Co....

2020-03-30 19:00 3242

Hotels Readiness Providing Accommodation for Medical Staff handling COVID-19 in Indonesia

JAKARTA, Indonesia, March 30, 2020 /PRNewswire/ -- Minister of Tourism and Creative Economy / Head of Tourism and Creative Economy Agency, Wishnutama Kusubandio - made sure that the hotels assigned to accommodate frontline medical personnel and task forces who are fighting the COVID-19 outbreak...

2020-03-30 14:44 2755

SHL Medical acquires Weibel CDS

ZUG, Switzerland, March 30, 2020 /PRNewswire/ -- SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging. Weibel was established i...

2020-03-30 14:00 1725

Vinamilk donates nearly 500,000 USD to COVID-19 fight

HO CHI MINH CITY, Vietnam, March 30, 2020 /PRNewswire/ -- Thousands of samples have been tested inVietnam for SARS-CoV-2 that causes COVID-19. However, multiple others, including foreigners, have remained in quarantine at residential areas and centralized quarantine centers.

2020-03-30 13:49 3326

CSPC Pharmaceutical Announces 2019 Annual Results

Profit Attributable To Shareholders Increased 20.6% to RMB3,714 Million Innovative Drug Business Continued to Deliver Strong Growth New Products Launched Helped to Sustain Growth HONG KONG, March 30, 2020 /PRNewswire/ -- CSPC Pharmaceutical Group Limited  (HKEx: 01093) ("CSPC Pharmaceutical" or the...

2020-03-30 12:34 3171

Vela Diagnostics to offer manual ViroKey™ SARS-CoV-2 RT-PCR Test after completion of Emergency Use Authorization validation, targeted to be complete by early April 2020

SINGAPORE, March 30, 2020 /PRNewswire/ -- Ahead of Emergency Use Authorization (EUA) and in accordance with the U.S. Food and Drug Administration (FDA) Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency guidance document issued on March 16, 2020, Vela Diag...

2020-03-30 12:06 1292

Dominguez urges more support and delegated authority for President Asakawa so ADB can respond swiftly to COVID-19 crisis

MANILA, Philippines, March 30, 2020 /PRNewswire/ -- Finance Secretary Carlos Dominguez III of Department of Finance, Republic of the Philippines has urged his fellow governors at the Asian Development Bank (ADB) to empower its President Mr. Masatsugu Asakawa with more discretion in undertaking m...

2020-03-30 11:25 1870

Infinitus offers 800,000 epidemic prevention supplies packages free to help create a safe workplace at its exclusive stores

GUANGZHOU, China, March 29, 2020 /PRNewswire/ -- China has currently achieved initial success in preventing and controlling COVID-19, however, the overall situation remains serious. With the large-scale return to work and resumption of production now taking place across the country, workplace saf...

2020-03-30 09:15 1419

Ascentage Pharma Releases 2019 Annual Results, Reports Increased Investment in R&D and Advances in Global Clinical Development

SUZHOU, China and ROCKVILLE, MD, March 29, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today released its annual results for the...

2020-03-30 08:00 1534

Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Device

The device is designed to restore vision to persons blinded by age-related macular degeneration and retinitis pigmentosa First two patients to receive the device in March 2020 report visual effect HERZLIYA, Israel, March 30, 2020 /PRNewswire/ -- Nano Retina Ltd., developer of the NR600, an artif...

2020-03-30 08:00 1714

Amerigo Education Responds to COVID-19 Impact

CHICAGO, March 29, 2020 /PRNewswire/ -- Amerigo Education, the leading provider of comprehensive boarding programs for international students, today shared its strategies to help protect students' health and wellbeing during the outbreak of coronavirus (COVID-19.) Amerigo started taking proactive...

2020-03-30 07:00 1305

Amerigo Education Responds to COVID-19 Impact

CHICAGO, March 30, 2020 /PRNewswire/ -- Amerigo Education, the leading provider of comprehensive boarding programs for international students, today shared its strategies to help protect students' health and wellbeing during the outbreak of coronavirus (COVID-19.) Amerigo started taking proactive...

2020-03-30 07:00 1962

Trip.com Group Chairman James Liang: Beware the xenophobia epidemic

SHANGHAI, March 29, 2020 /PRNewswire/ -- James Liang is an economist and entrepreneur. Trip.com Group Ltd. is one of the world's largest OTAs. The following are his thoughts on current events. These opinions are his own, and do not necessarily reflect those of Trip.com Group Ltd. as a whole: The...

2020-03-29 20:07 1694

Ping An Donates US$1.5 million of COVID-19 Medical Supplies to Indonesia

HONG KONG and SHANGHAI, March 28, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) announced that in response to the Extraordinary G20 Leaders' Summit's call to supportIndonesia in fighting the COVID-19 epidemic, Ping...

2020-03-28 00:57 9493

GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial

NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment) announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is ...

2020-03-27 21:00 2145

GenScript ProBio Congratulates XlifeSciences on the Start of TAEST16001 Early Phase Clinical Trial

NANJING, China, March 27, 2020 /PRNewswire/ -- Guangzhou XlifeSciences, a partner of GenScript ProBio (GenScript's CDMO segment), announced that the early phase clinical trial of TAEST16001 project has been started. GenScript ProBio extends congratulations on this. This clinical trial project is...

2020-03-27 21:00 2569
1 ... 720721722723724725726 ... 820